
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
5 Movies That Leaving an Imprint with Inventive Innovation - 2
Man who grabbed Ariana Grande at 'Wicked: For Good' premiere also rushed Katy Perry onstage this year. Who is he and why is he doing this? - 3
Drenched in Pixels: A Survey of \Vivid Interactivity Experience\ Game - 4
AI is making spacecraft propulsion more efficient – and could even lead to nuclear-powered rockets - 5
Turning to turkey’s tryptophan to boost mood? Not so fast
Uncover the Manageable Fish Practices: Sea agreeable Feasting
Manual for 10 Scrumptious Specialty Mixed drinks
BravoCon 2025: How to watch, full schedule and lineup, where to stream free and more
AstraZeneca to invest $2 billion as part of US manufacturing push
Changes to CDC website spark debate over autism and vaccine misinformation
Invigorating Spots To Go Kayaking All over The Planet
Figure out How to Augment Your Rooftop Substitution Speculation
The Ascent of Rousing Pioneers Who Formed History
Vote in favor of your #1 sort of juice












